Compare · CGC vs TLRY
CGC vs TLRY
Side-by-side comparison of Canopy Growth Corporation (CGC) and Tilray Brands Inc. (TLRY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CGC and TLRY operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- CGC is the larger of the two at $2.86B, about 5.4x TLRY ($532.5M).
- TLRY has been more active in the news (16 items in the past 4 weeks vs 6 for CGC).
- CGC has more recent analyst coverage (19 ratings vs 14 for TLRY).
- Company
- Canopy Growth Corporation
- Tilray Brands Inc.
- Price
- -
- -
- Market cap
- $2.86B
- $532.5M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NYSE
- NASDAQ
- IPO
- 2018
- News (4w)
- 6
- 16
- Recent ratings
- 19
- 14
Canopy Growth Corporation
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Tilray Brands Inc.
Tilray, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York.
Latest CGC
- Officer Gedeon Christelle sold $19,616 worth of shares (13,344 units at $1.47), decreasing direct ownership by 2% to 692,162 units (SEC Form 4) to cover taxes
- Officer Stewart Thomas Carlton sold $3,280 worth of shares (2,231 units at $1.47), decreasing direct ownership by 0.36% to 614,167 units (SEC Form 4) to satisfy withholding obligation
- SEC Form DEFA14A filed by Canopy Growth Corporation
- Canopy Growth Announces Mailing of Proxy Materials for 2026 Annual General and Special Meeting – Urges Shareholders to Vote Now
- SEC Form DEFA14A filed by Canopy Growth Corporation
- Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business Grows
- SEC Form DEFA14A filed by Canopy Growth Corporation
- SEC Form DEF 14A filed by Canopy Growth Corporation
- Canopy Growth Corporation filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
- Canopy Growth Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
Latest TLRY
- Award-Winning BrewDog Unleashes Liquid Visions, a Bold New Craft Beer Series Built to Light Up Retail Shelves
- President and CEO Simon Irwin D converted options into 1,212,168 shares and covered exercise/tax liability with 642,450 shares, increasing direct ownership by 77% to 1,309,031 units (SEC Form 4) to satisfy tax liability
- Chief Financial Officer Merton Carl A converted options into 168,452 shares and covered exercise/tax liability with 92,649 shares, increasing direct ownership by 54% to 215,556 units (SEC Form 4) (tax liability)
- Global General Counsel Gendel Mitchell converted options into 160,304 shares and covered exercise/tax liability with 84,962 shares, increasing direct ownership by 60% to 200,225 units (SEC Form 4) to cover taxes
- Chief Strategy Officer Faltischek Denise M converted options into 178,221 shares and covered exercise/tax liability with 94,459 shares, increasing direct ownership by 59% to 225,047 units (SEC Form 4) (tax withholding)
- BrewDog Wins Big at the 2026 World Beer Awards with a Sweeping Show of Brewing Excellence
- Tilray Strengthens Global Medical Cannabis Leadership with Major Production Increase to Meet International Demand
- BrewDog Unwraps Its 2026 Advent Calendar
- Tilray Medical Welcomes Progress in Germany’s Medical Cannabis Framework and Supports Continued Policy Development
- Montauk Brewing Company Expands Its Coastal Footprint with New North Shore Brewpub